NASDAQ:LPCN
Lipocine Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.lipocine.comipo date
Oct 22, 2013
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's p...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus